Market Overview:
The global albumin market reached a value of US$ 5.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.7 Billion by 2027, exhibiting a CAGR of 6.15% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Albumin is a water-soluble globular protein present in blood plasma. It is synthesized in the liver and is essential for maintaining the blood volume and transportation of enzyme, hormone and bile salt molecules. It is commonly available in human, bovine and recombinant variants. They are crucial for sustaining the intravascular colloid osmotic pressure (COP) and preventing leakage of fluids into the tissue. It is commonly used as a blood volumizer for the treatment of rare diseases, burns, liver disorders, blood loss trauma and surgical complications. It is also utilized in pharmaceutical drugs for stabilization, enhancing surface absorption and reducing aggregation and oxidation. As a result, albumin finds extensive application in the manufacturing of drug delivery systems, therapeutics, culture media and vaccines.
Albumin Market Trends:
The increasing prevalence of chronic medical ailments across the globe is one of the key factors driving the growth of the market. Albumin is widely used in the treatment of hypovolemia, acute respiratory distress syndrome, nephrosis, renal dialysis, liver failure, cardiopulmonary disorders and hypoalbuminemia. Moreover, the rising geriatric population, which is more susceptible to such ailments is providing a thrust to the market growth. Additionally, the widespread adoption of human serum albumin (HSA) for replenishing proteins in human plasma and maintaining plasma colloid oncotic pressure is acting as another growth-inducing factor. It also aids in preventing the denaturation of active protein ingredients, thereby making it highly beneficial for the production of vaccines. Other factors, including the introduction of albumin-based nanoparticles, along with extensive research and development (R&D) activities in the field of biotechnology, are anticipated to drive the market toward growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global albumin market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
- Human Serum Albumin
- Bovine Serum Albumin
- Recombinant Albumin
Breakup by Application:
- Therapeutics
- Drug Formulation and Vaccine
- Component of Media
- Others
Breakup by End User:
- Hospitals and Clinics
- Pharmaceutical and Biotechnology Companies
- Research Institutes
Breakup by Region:
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Albumedix Ltd, Biotest AG, Celgene Corporation (Bristol-Myers Squibb Company), CSL Limited, Grifols SA, HiMedia Laboratories, Medxbio Pte Ltd, Merck KGaA, Octapharma AG, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc. and Ventria Bioscience Inc.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Product, Application, End User, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Albumedix Ltd, Biotest AG, Celgene Corporation (Bristol-Myers Squibb Company), CSL Limited, Grifols SA, HiMedia Laboratories, Medxbio Pte Ltd, Merck KGaA, Octapharma AG, Takeda Pharmaceutical Company Limited, Thermo Fisher Scientific Inc. and Ventria Bioscience Inc. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global albumin market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global albumin market?
- What are the key regional markets?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global albumin market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Albumin Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Human Serum Albumin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Bovine Serum Albumin
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Recombinant Albumin
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Application
7.1 Therapeutics
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Drug Formulation and Vaccine
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Component of Media
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Pharmaceutical and Biotechnology Companies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Research Institutes
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Albumedix Ltd
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.2 Biotest AG
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Celgene Corporation (Bristol-Myers Squibb Company)
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 SWOT Analysis
14.3.4 CSL Limited
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Grifols SA
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 HiMedia Laboratories
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.7 Medxbio Pte Ltd
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Merck KGaA
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Octapharma AG
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 SWOT Analysis
14.3.10 Takeda Pharmaceutical Company Limited
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Thermo Fisher Scientific Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Ventria Bioscience Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
List of Figures
Figure 1: Global: Albumin Market: Major Drivers and Challenges
Figure 2: Global: Albumin Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Albumin Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Albumin Market: Breakup by Product (in %), 2021
Figure 5: Global: Albumin Market: Breakup by Application (in %), 2021
Figure 6: Global: Albumin Market: Breakup by End User (in %), 2021
Figure 7: Global: Albumin Market: Breakup by Region (in %), 2021
Figure 8: Global: Albumin (Human Serum Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Albumin (Human Serum Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Albumin (Bovine Serum Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Albumin (Bovine Serum Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Albumin (Recombinant Albumin) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Albumin (Recombinant Albumin) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Albumin (Therapeutics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Albumin (Therapeutics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Albumin (Drug Formulation and Vaccine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Albumin (Drug Formulation and Vaccine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Albumin (Component of Media) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Albumin (Component of Media) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Albumin (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Albumin (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Albumin (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Albumin (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Albumin (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Albumin (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Albumin (Research Institutes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Albumin (Research Institutes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: North America: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: North America: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: United States: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: United States: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Canada: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Canada: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia-Pacific: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia-Pacific: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: China: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: China: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Japan: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Japan: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: India: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: India: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: South Korea: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: South Korea: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Australia: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Australia: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Indonesia: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Indonesia: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Others: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Others: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Europe: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Europe: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Germany: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Germany: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: France: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: France: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: United Kingdom: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: United Kingdom: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Italy: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Italy: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Spain: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Spain: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Russia: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Russia: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Others: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Others: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Brazil: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Brazil: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Mexico: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Mexico: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Middle East and Africa: Albumin Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Middle East and Africa: Albumin Market: Breakup by Country (in %), 2021
Figure 76: Middle East and Africa: Albumin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 77: Global: Albumin Industry: SWOT Analysis
Figure 78: Global: Albumin Industry: Value Chain Analysis
Figure 79: Global: Albumin Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Albumin Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Albumin Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Albumin Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Albumin Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Albumin Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Albumin Market: Competitive Structure
Table 7: Global: Albumin Market: Key Players